Regulation of Oncogenic Targets by miR-99a-3p (Passenger Strand of miR-99a-Duplex) in Head and Neck Squamous Cell Carcinoma

被引:33
作者
Okada, Reona [1 ]
Koshizuka, Keiichi [1 ,2 ]
Yamada, Yasutaka [1 ]
Moriya, Shogo [3 ]
Kikkawa, Naoko [1 ,2 ]
Kinoshita, Takashi [2 ]
Hanazawa, Toyoyuki [2 ]
Seki, Naohiko [1 ]
机构
[1] Chiba Univ, Dept Funct Genom, Grad Sch Med, Chiba 2608670, Japan
[2] Chiba Univ, Dept Otorhinolaryngol Head & Neck Surg, Grad Sch Med, Chiba 2608670, Japan
[3] Chiba Univ, Dept Biochem & Genet, Grad Sch Med, Chiba 2608670, Japan
关键词
head and neck squamous cell carcinoma; microRNA; miR-99a-3p; passenger strand; antitumor; STAMBP; TUMOR-SUPPRESSOR; CANCER; EXPRESSION; AMSH; MIR-145-3P; MIGRATION; INVASION; DEUBIQUITINATION; PHOSPHORYLATION; IDENTIFICATION;
D O I
10.3390/cells8121535
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
To identify novel oncogenic targets in head and neck squamous cell carcinoma (HNSCC), we have analyzed antitumor microRNAs (miRNAs) and their controlled molecular networks in HNSCC cells. Based on our miRNA signature in HNSCC, both strands of the miR-99a-duplex (miR-99a-5p: the guide strand, and miR-99a-3p: the passenger strand) are downregulated in cancer tissues. Moreover, low expression of miR-99a-5p and miR-99a-3p significantly predicts poor prognosis in HNSCC, and these miRNAs regulate cancer cell migration and invasion. We previously showed that passenger strands of miRNAs have antitumor functions. Here, we screened miR-99a-3p-controlled oncogenes involved in HNSCC pathogenesis. Thirty-two genes were identified as miR-99a-3p-regulated genes, and 10 genes (STAMBP, TIMP4, TMEM14C, CANX, SUV420H1, HSP90B1, PDIA3, MTHFD2, BCAT1, and SLC22A15) significantly predicted 5-year overall survival. Notably, among these genes, STAMBP, TIMP4, TMEM14C, CANX, and SUV420H1 were independent prognostic markers of HNSCC by multivariate analyses. We further investigated the oncogenic function of STAMBP in HNSCC cells using knockdown assays. Our data demonstrated that the aggressiveness of phenotypes in HNSCC cells was attenuated by siSTAMBP transfection. Moreover, aberrant STAMBP expression was detected in HNSCC clinical specimens by immunohistochemistry. This strategy may contribute to the clarification of the molecular pathogenesis of this disease.
引用
收藏
页数:18
相关论文
共 53 条
  • [31] Targeting of AMSH to endosomes is required for epidermal growth factor receptor degradation
    Ma, Yu May
    Boucrot, Emmanuel
    Villen, Judit
    Affar, El Bachir
    Gygi, Steven P.
    Goettlinger, Heinrich G.
    Kirchhausen, Tomas
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (13) : 9805 - 9812
  • [32] AMSH is an endosome-associated ubiquitin isopeptidase
    McCullough, J
    Clague, MJ
    Urbé, S
    [J]. JOURNAL OF CELL BIOLOGY, 2004, 166 (04) : 487 - 492
  • [33] Mutations in STAMBP, encoding a deubiquitinating enzyme, cause microcephaly-capillary malformation syndrome
    McDonell, Laura M.
    Mirzaa, Ghayda M.
    Alcantara, Diana
    Schwartzentruber, Jeremy
    Carter, Melissa T.
    Lee, Leo J.
    Clericuzio, Carol L.
    Graham, John M., Jr.
    Morris-Rosendahl, Deborah J.
    Polster, Tilman
    Acsadi, Gyula
    Townshend, Sharron
    Williams, Simon
    Halbert, Anne
    Isidor, Bertrand
    David, Albert
    Smyser, Christopher D.
    Paciorkowski, Alex R.
    Willing, Marcia
    Woulfe, John
    Das, Soma
    Beaulieu, Chandree L.
    Marcadier, Janet
    Geraghty, Michael T.
    Frey, Brendan J.
    Majewski, Jacek
    Bulman, Dennis E.
    Dobyns, William B.
    O'Driscoll, Mark
    Boycott, Kym M.
    [J]. NATURE GENETICS, 2013, 45 (05) : 556 - U136
  • [34] Recycling of EGFR and ErbB2 is associated with impaired Hrs tyrosine phosphorylation and decreased deubiquitination by AMSH
    Meijer, Inez M. J.
    van Rotterdam, Walter
    van Zoelen, Everardus J. J.
    van Leeuwen, Jeroen E. M.
    [J]. CELLULAR SIGNALLING, 2012, 24 (11) : 1981 - 1988
  • [35] Molecular Pathogenesis of Gene Regulation by the miR-150 Duplex: miR-150-3p Regulates TNS4 in Lung Adenocarcinoma
    Misono, Shunsuke
    Seki, Naohiko
    Mizuno, Keiko
    Yamada, Yasutaka
    Uchida, Akifumi
    Sanada, Hiroki
    Moriya, Shogo
    Kikkawa, Naoko
    Kumamoto, Tomohiro
    Suetsugu, Takayuki
    Inoue, Hiromasa
    [J]. CANCERS, 2019, 11 (05)
  • [36] Dual strands of the miR-145 duplex (miR-145-5p and miR-145-3p) regulate oncogenes in lung adenocarcinoma pathogenesis
    Misono, Shunsuke
    Seki, Naohiko
    Mizuno, Keiko
    Yamada, Yasutaka
    Uchida, Akifumi
    Arai, Takayuki
    Kumamoto, Tomohiro
    Sanada, Hiroki
    Suetsugu, Takayuki
    Inoue, Hiromasa
    [J]. JOURNAL OF HUMAN GENETICS, 2018, 63 (10) : 1015 - 1028
  • [37] Tumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinoma
    Nohata, N.
    Hanazawa, T.
    Kikkawa, N.
    Sakurai, D.
    Fujimura, L.
    Chiyomaru, T.
    Kawakami, K.
    Yoshino, H.
    Enokida, H.
    Nakagawa, M.
    Katayama, A.
    Harabuchi, Y.
    Okamoto, Y.
    Seki, N.
    [J]. BRITISH JOURNAL OF CANCER, 2011, 105 (06) : 833 - 841
  • [38] MicroRNAs function as tumor suppressors or oncogenes: Aberrant expression of microRNAs in head and neck squamous cell carcinoma
    Nohata, Nijiro
    Hanazawa, Toyoyuki
    Kinoshita, Takashi
    Okamoto, Yoshitaka
    Seki, Naohiko
    [J]. AURIS NASUS LARYNX, 2013, 40 (02) : 143 - 149
  • [39] Potential tumor-suppressive role of microRNA-99a-3p in sunitinib-resistant renal cell carcinoma cells through the regulation of RRM2
    Osako, Yoichi
    Yoshino, Hirofumi
    Sakaguchi, Takashi
    Sugita, Satoshi
    Yonemori, Masaya
    Nakagawa, Masayuki
    Enokida, Hideki
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 54 (05) : 1759 - 1770
  • [40] MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
    Rupaimoole, Rajesha
    Slack, Frank J.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (03) : 203 - 221